Stephen Sanders

Array ( [id] => 9865274 [patent_doc_number] => 20150045294 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-02-12 [patent_title] => 'ENERGY-RICH LIQUID NUTRITIONAL COMPOSITION HAVING IMPROVED ORGANOLEPTIC PROPERTIES' [patent_app_type] => utility [patent_app_number] => 14/381173 [patent_app_country] => US [patent_app_date] => 2013-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9942 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14381173 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9857347 [patent_doc_number] => 20150037359 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-02-05 [patent_title] => 'XTEN CONJUGATE COMPOSITIONS AND METHODS OF MAKING SAME' [patent_app_type] => utility [patent_app_number] => 14/381199 [patent_app_country] => US [patent_app_date] => 2013-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 119 [patent_figures_cnt] => 119 [patent_no_of_words] => 144650 [patent_no_of_claims] => 154 [patent_no_of_ind_claims] => 34 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14381199 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9831889 [patent_doc_number] => 08940703 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-01-27 [patent_title] => 'Inhibitors of TLR signaling by targeting TIR domain interfaces' [patent_app_type] => utility [patent_app_number] => 13/761277 [patent_app_country] => US [patent_app_date] => 2013-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 17732 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 197 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13761277 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8962948 [patent_doc_number] => 20130202550 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-08 [patent_title] => 'NON-ANTICOAGULANT SULFATED OR SULFONATED SYNTHETIC POLYMERS' [patent_app_type] => utility [patent_app_number] => 13/754727 [patent_app_country] => US [patent_app_date] => 2013-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 17599 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13754727 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8976014 [patent_doc_number] => 20130209444 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-15 [patent_title] => 'NON-ANTICOAGULANT SULFATED OR SULFONATED POLYSACCHARIDES' [patent_app_type] => utility [patent_app_number] => 13/754575 [patent_app_country] => US [patent_app_date] => 2013-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 92 [patent_figures_cnt] => 92 [patent_no_of_words] => 24890 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13754575 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8950646 [patent_doc_number] => 20130196427 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-01 [patent_title] => 'CANCER ANTIGEN PEPTIDES DERIVED FROM WT1' [patent_app_type] => utility [patent_app_number] => 13/748984 [patent_app_country] => US [patent_app_date] => 2013-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12486 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13748984 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10548481 [patent_doc_number] => 09273092 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-03-01 [patent_title] => 'Selective binding compounds' [patent_app_type] => utility [patent_app_number] => 13/726112 [patent_app_country] => US [patent_app_date] => 2012-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5508 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13726112 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9545480 [patent_doc_number] => 20140170128 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-06-19 [patent_title] => 'COMPOSITIONS FOR THE MANAGEMENT OF GLYCATED HEMOGLOBIN AND BLOOD GLUCOSE' [patent_app_type] => utility [patent_app_number] => 13/717305 [patent_app_country] => US [patent_app_date] => 2012-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10984 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13717305 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8892200 [patent_doc_number] => 20130165384 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-27 [patent_title] => 'Decellularized small particle tissue' [patent_app_type] => utility [patent_app_number] => 13/694586 [patent_app_country] => US [patent_app_date] => 2012-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4421 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13694586 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10405325 [patent_doc_number] => 20150290335 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-15 [patent_title] => 'BILE ACID OLIGOMER CONJUGATE FOR NOVEL VESICULAR TRANSPORT AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 14/437477 [patent_app_country] => US [patent_app_date] => 2012-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 13489 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14437477 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8891608 [patent_doc_number] => 20130164792 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-27 [patent_title] => 'METHOD FOR PRODUCING CRYSTALS OF MUTIVALENT METAL SALT OF (2R, 4R) MONATIN' [patent_app_type] => utility [patent_app_number] => 13/678909 [patent_app_country] => US [patent_app_date] => 2012-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 15762 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13678909 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8815359 [patent_doc_number] => 20130116404 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-09 [patent_title] => 'TARGETED NON-INVASIVE IMAGING PROBES OF EGFR EXPRESSING CELLS' [patent_app_type] => utility [patent_app_number] => 13/671957 [patent_app_country] => US [patent_app_date] => 2012-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8146 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13671957 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17844918 [patent_doc_number] => 11434271 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-09-06 [patent_title] => Method for preparing physiologically active polypeptide complex [patent_app_type] => utility [patent_app_number] => 14/356054 [patent_app_country] => US [patent_app_date] => 2012-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 7431 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 284 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14356054 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9772468 [patent_doc_number] => 20140296132 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-02 [patent_title] => 'Anti-bacterial Polypeptides and Pathogen Specific Synthetic Antibodies' [patent_app_type] => utility [patent_app_number] => 14/355839 [patent_app_country] => US [patent_app_date] => 2012-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6265 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14355839 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8779691 [patent_doc_number] => 20130101666 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-25 [patent_title] => 'LIPOSOME INCLUDING ELASTIN-LIKE POLYPEPTIDE CONJUGATED TO MOIETY CONTAINING HYDROPHOBIC GROUP, CHEMOSENSITIZER AND ANTICANCER AGENT AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/656586 [patent_app_country] => US [patent_app_date] => 2012-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 10075 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13656586 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9785351 [patent_doc_number] => 20140302171 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-09 [patent_title] => 'Cysteine Peptide-Containing Health Drink' [patent_app_type] => utility [patent_app_number] => 14/350519 [patent_app_country] => US [patent_app_date] => 2012-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 11293 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14350519 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8892206 [patent_doc_number] => 20130165389 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-27 [patent_title] => 'BINDING FUSION PROTEINS, BINDING FUSION PROTEIN-DRUG CONJUGATES, XTEN-DRUG CONJUGATES AND METHODS OF MAKING AND USING SAME' [patent_app_type] => utility [patent_app_number] => 13/631361 [patent_app_country] => US [patent_app_date] => 2012-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 51 [patent_figures_cnt] => 51 [patent_no_of_words] => 115576 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13631361 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9657276 [patent_doc_number] => 20140228281 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-14 [patent_title] => 'ALISPORIVR FOR TREATMENT OF HEPATITIS C VIRUS INFECTION' [patent_app_type] => utility [patent_app_number] => 14/347013 [patent_app_country] => US [patent_app_date] => 2012-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6006 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14347013 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9148958 [patent_doc_number] => 20130303482 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-14 [patent_title] => 'Cylodextrin Complexation Methods for Formulating Peptide Proteasome Inhibitors' [patent_app_type] => utility [patent_app_number] => 13/614829 [patent_app_country] => US [patent_app_date] => 2012-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 31472 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13614829 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9148942 [patent_doc_number] => 20130303465 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-14 [patent_title] => 'Cylodextrin Complexation Methods for Formulating Peptide Proteasome Inhibitors' [patent_app_type] => utility [patent_app_number] => 13/614599 [patent_app_country] => US [patent_app_date] => 2012-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 31461 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13614599 [rel_patent_id] =>[rel_patent_doc_number] =>)